Literature DB >> 24647998

miR-1303 targets claudin-18 gene to modulate proliferation and invasion of gastric cancer cells.

Shi-jie Zhang1, Jian-fang Feng, Lei Wang, Wei Guo, Yu-wen Du, Liang Ming, Guo-qiang Zhao.   

Abstract

BACKGROUND: MicroRNAs have emerged as important gene regulators and are recognized as important molecules in carcinogenesis. However, the effects of microRNA-1303 (miR-1303) on gastric cancer (GC) cells and the upstream regulation of GC-associated claudin-18 gene (CLDN18) remain unclear. miR-1303 may be involved in the tumorigenesis of GC by targeting CLDN18. AIMS: The purpose of this study was to explore the effect of miR-1303 targeting of CLDN18 on the proliferation, migration and invasion of human GC cells.
METHODS: The expression of miR-1303 and claudin-18 in GC tissues and gastric cancer cell lines were detected by qRT-PCR and western blotting, respectively. CCK8 and colony formation assays were performed to study the influence of miR-1303 on the proliferation of the GC cell lines. Transwell and wound-healing assays were carried out to investigate the effect of miR-1303 on the invasion and migration of GC cell lines. Luciferase reporter assays, restore assays and western blotting were used to demonstrate whether CLDN18 is a direct target of miR-1303.
RESULTS: miR-1303 was significantly overexpressed whereas claudin-18 was downregulated in GC tissues and cell lines, which was significantly associated with tumor size, location invasion, histologic type and tumor-node-metastasis stage. Cell proliferation rates were reduced, and cell invasion and migratory ability was significantly restricted in miR-1303 inhibitor-transfected groups. miR-1303 could bind to the putative binding sites in CLDN18 mRNA 3'-UTR and visibly lower the expression of claudin-18. The introduction of claudin-18 without 3'-UTR restored the miR-1303 promoting migration function.
CONCLUSIONS: Downregulation of miR-1303 can inhibit proliferation, migration and invasion of GC cells by targeting CLDN18.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24647998     DOI: 10.1007/s10620-014-3107-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer.

Authors:  Matthias P A Ebert; Guo Fei; Sabine Kahmann; Oliver Müller; Jun Yu; Joseph J Y Sung; Peter Malfertheiner
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

3.  MicroRNAs as a potential prognostic factor in gastric cancer.

Authors:  Baruch Brenner; Moshe B Hoshen; Ofer Purim; Miriam Ben David; Karin Ashkenazi; Gideon Marshak; Yulia Kundel; Ronen Brenner; Sara Morgenstern; Marisa Halpern; Nitzan Rosenfeld; Ayelet Chajut; Yaron Niv; Michal Kushnir
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

4.  Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers.

Authors:  Zsuzsanna Németh; Attila Marcell Szász; Péter Tátrai; Júlia Németh; Hajnalka Gyorffy; Aron Somorácz; Attila Szíjártó; Péter Kupcsulik; András Kiss; Zsuzsa Schaff
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

5.  Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.

Authors:  Ugur Sahin; Michael Koslowski; Karl Dhaene; Dirk Usener; Gunda Brandenburg; Gerhard Seitz; Christoph Huber; Ozlem Türeci
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

6.  The diagnostic and prognostic utility of claudin expression in renal cell neoplasms.

Authors:  Mirna Lechpammer; Murray B Resnick; Edmond Sabo; Evgeny Yakirevich; Wesley O Greaves; Katherine T Sciandra; Rosemarie Tavares; Lelia C Noble; Ronald A DeLellis; Li J Wang
Journal:  Mod Pathol       Date:  2008-06-27       Impact factor: 7.842

7.  Gastric and intestinal claudin expression at the invasive front of gastric carcinoma.

Authors:  Yoshiko Matsuda; Shuho Semba; Junya Ueda; Takeichi Fuku; Tadateru Hasuo; Hideki Chiba; Norimasa Sawada; Yoshikazu Kuroda; Hiroshi Yokozaki
Journal:  Cancer Sci       Date:  2007-04-24       Impact factor: 6.716

8.  Identification of recurrence-related genes by integrating microRNA and gene expression profiling of gastric cancer.

Authors:  Zhi Yan; Yimin Xiong; Weitian Xu; Min Li; Yi Cheng; Fang Chen; Shifang Ding; Hualin Xu; Guorong Zheng
Journal:  Int J Oncol       Date:  2012-09-24       Impact factor: 5.650

Review 9.  Molecular basis of gastric cancer development and progression.

Authors:  Leizhen Zheng; Liwei Wang; Jaffer Ajani; Keping Xie
Journal:  Gastric Cancer       Date:  2004       Impact factor: 7.370

10.  Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front.

Authors:  Tadayuki Oshima; Jing Shan; Takuya Okugawa; Xin Chen; Kazutoshi Hori; Toshihiko Tomita; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

View more
  20 in total

1.  Circulating MicroRNAs in Relation to Esophageal Adenocarcinoma Diagnosis and Survival.

Authors:  Jessica L Petrick; Ruth M Pfeiffer; Linda M Liao; Christian C Abnet; Xiaolin Wu; Marilie D Gammon; Thomas L Vaughan; Michael B Cook
Journal:  Dig Dis Sci       Date:  2021-01-06       Impact factor: 3.199

Review 2.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

Review 3.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

4.  miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells.

Authors:  Xiaonan Chen; Yuanyuan Wang; Wenqiao Zang; Yuwen Du; Min Li; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-11-21

5.  Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.

Authors:  Yadong Wang; Shanfeng Zhang; Yan Xu; Yan Zhang; Hongya Guan; Xinjie Li; Yuebai Li; Yisheng Wang
Journal:  Tumour Biol       Date:  2016-09-28

Review 6.  Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier.

Authors:  Tyler J Caron; Kathleen E Scott; James G Fox; Susan J Hagen
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

7.  The mutual regulatory loop between TPTEP1 and miR-1303 in leukemogenesis of acute myeloid leukemia.

Authors:  Li Li; Weidong Zhao
Journal:  Cancer Cell Int       Date:  2021-05-13       Impact factor: 5.722

8.  Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells.

Authors:  Hiroyuki Sonoki; Tomonari Sato; Satoshi Endo; Toshiyuki Matsunaga; Masahiko Yamaguchi; Yasuhiro Yamazaki; Junko Sugatani; Akira Ikari
Journal:  Nutrients       Date:  2015-06-08       Impact factor: 5.717

Review 9.  Tight junction proteins in gastrointestinal and liver disease.

Authors:  Mirjam B Zeisel; Punita Dhawan; Thomas F Baumert
Journal:  Gut       Date:  2018-10-08       Impact factor: 31.793

10.  Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus.

Authors:  Cheng Wang; Shujun Wan; Ting Yang; Dongmei Niu; Aisen Zhang; Cuihua Yang; Jialu Cai; Jia Wu; Jiaxi Song; Chen-Yu Zhang; Chunni Zhang; Junjun Wang
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.